Navigation Links
David Barker, Former Illumina CSO, Joins GenVault's Scientific Advisory Board
Date:9/28/2007

CARLSBAD, Calif., Sept. 28 /PRNewswire/ -- GenVault Corporation today announces that industry expert David Barker Ph.D. has joined its Scientific Advisory Board. In his role on the board, Dr. Barker will provide scientific guidance facilitating GenVault's entry into new biosample management markets. Dr. Barker brings more than 20 years experience in life science product commercialization as well as experience in serving on the boards of companies such as NextBio, Cell Biosciences, and Microchip Biotechnologies.

"Dr. Barker's extraordinarily deep understanding of the industry and its future will be extremely valuable as we chart our vision. We are very honored to welcome Dr. Barker as a key member of the GenVault advisory team," said David Wellis, CEO of GenVault

"Well-characterized biological samples and their intelligent storage and retrieval are essential for discovering disease genes and biomarkers. I am pleased to be asked to participate in GenVault's creative solutions for sample management " said Dr. Barker

Dr. Barker's previous product commercialization experience includes senior positions at Illumina as Vice President and Chief Scientific Officer; Amersham Biosciences as Vice President and Chief Science Advisor and Molecular Dynamics as Vice President of Research and Business Development until its acquisition by Amersham Biosciences. In his academic career, Dr. Barker conducted interdisciplinary research in neurobiology as a postdoctoral fellow at Harvard Medical School, Assistant Professor at the University of Oregon and Associate Professor at Oregon State University. Dr. Barker holds a BS with honors in Chemistry from the California Institute of Technology and a PhD in Biochemistry from Brandeis University.

About GenVault

GenVault is redefining the global standard in biosample workflow and storage solutions for genomic medicine, discovery and identification. The company's room temperature technology reduces costs and em
'/>"/>

SOURCE GenVault Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. David Brooks: Segmented nation looks for solidarity amid IT-powered niches
3. CIO Leadership Series: Rick Davidson, Manpower
4. CIO Leadership Series: David Melbye, Milwaukee Metro Sewerage District
5. CIO Leadership Series: David Cagigal, Alliant Energy
6. Former Fiserv exec to enter Business Hall of Fame
7. UW scientist, former WiCell director found stem cell company
8. Kyron appoints former AMA chairman to board
9. Genzyme sues former Bone Care employees
10. Former astronaut a leader in Wisconsin Spaceport
11. New book from former CDC CEO walks readers through innovation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...mbassador to also Visit Detroit , ...vid Appia, French Ambassador for International Inv...nce Agency, , , , ,What: Ambassador Appia is avai...iness initiatives adopted by France to further dev...for innovation and development., , ,When: Availabl...
(Date:11/24/2009)...ewswire-FirstCall/--Sigma-AldrichCorporation(Nasda...nTuesday,December1stat1:45PMGMTinLondon,7:45AMUS/C...overtheInternetavailableat http://inve s tor.si..."icontoaccessthisfile. ,, AboutSigma-Aldrich:...ogycompany.Itschemicalandbiochemicalproductsandkit...
(Date:11/24/2009)...ewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chinese...he,investigationalnewdrugapplication(IND)foritsora...ationtotreatdiabetes.ThisIND,approvalallowsBiolaxy...etesisadisordercharacteristicofhighbloodglucoseand...ultinseveremicro-and,macro-vasculardiseases,lossof...
(Date:11/24/2009)...RNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SH...oday,announcedthatithassubmittedaMAAtotheEuropeanM...zymereplacementtherapyindevelopment,forthetreatmen...licationforvelaglucerasealfathathasbeensubmitted,w... , Basedonaglobalsupplyshortageofthecurrently...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...nEarth Inc.,(OTC Bulletin Board: RNER; "the Compan...k Resources Inc. has been assigned a new symbol to... has become effective on May 21, 2009,according to... in conducting Hollow Fiber Mambrane,Materials, ap... Company has,launched a new English web site. The ...
...n provided jointly by leading international cardio... Investigators from the Phase III TRITON-TIMI 38 ...e Universal Definition of Myocardial Infarction to... with acute coronary syndromes (ACS) undergoing pe...prasugrel, as compared with patients taking clopid...
...AM, May 21 ,Agendia, a world leader in molecular c...searchers from Agendia, the University of Califor...itute will present data from multiple studies,at t...eting, May 29 - June 2,2009, in Orlando, Florida. ... predictive and prognostic,power of Agendia,s brea...
Other Biology Technology:RainEarth Inc. Changes Trading Symbol from GRKR to RNER 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 2Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 3
(Date:11/23/2009)...by University of Alabama at Birmingham (UAB) resea...sting medical conditions (co-morbidity) do not exp...-Americans compared to Caucasians who also have co...in Cancer , a journal of the American Cancer Soci...nd co-morbidity are independent predictors of poor...
(Date:11/23/2009)...eveal in unprecedented detail how the ribosome int...ns and guide them toward their destination in biol...flexible fitting (MDFF) to examine the interaction...ners. , The first study, in Proceedings of the...ate signaling between the ribosome and an elongati...
(Date:11/23/2009)...t discoveries about the multiple health benefits o...pose nutrient, increased awareness of the huge num...search and even led to an appreciation of it as "n...e health of your immune system to prevention of he...itamin D is now seen as one of the most critical n...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Jeff Stewart Joins Decision Resources Inc as Chief Information Officer 50277 1Jeff Stewart Joins Decision Resources Inc as Chief Information Officer 50277 2BioStorage Technologies Inc Appoints Jeff Goddard to Global Head of Sales 12825 1BioStorage Technologies Inc Appoints Jeff Goddard to Global Head of Sales 12825 2Retirement Cruise Ship Nearing Launch 50276 1Retirement Cruise Ship Nearing Launch 50276 2
...,s Research Hospital have found key features that ...those that infect humans. , The St. Jude team us...mino acid building blocks that are statistically m...eins and those that are more likely to be in human...e amino acids can be used as markers to track chan...
...le with its front legs, how do its hind legs know ...f Current Biology, a publication of Cell Press, re...elf that leaves a lasting impression. By compariso... proved rather fleeting. , Indeed, the researche...ver a hurdle for at least ten minutes. The finding...
...rsity scientists have developed tiny, spherical na...drate-based drugs. The scientists created the nano...TRP), which will ultimately enable the nanogels to...ispense the drug in a time-release manner. , The ... many unique properties that make them ideal drug-...
Other Biology News:St. Jude influenza survey uncovers key differences between bird flu and human flu 2St. Jude influenza survey uncovers key differences between bird flu and human flu 3Tracking feline memories on the move 2Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs 2
...l Clamp One can operate as a Voltage Clamp, as a C...n electrophysiology research applications. Perform...alog equipment. • This amazing instrument...apabilities of Digital Signal Processing (DSP) int...
Dispensing Bins from Terra Universal, Inc.
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
Apparel Dispenser from Terra Universal, Inc.
Biology Products: